SHEPHERD Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- SHEPHERD Therapeutics's estimated annual revenue is currently $1.1M per year.
- SHEPHERD Therapeutics's estimated revenue per employee is $155,000
Employee Data
- SHEPHERD Therapeutics has 7 Employees.
- SHEPHERD Therapeutics grew their employee count by -53% last year.
SHEPHERD Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | founder, patient & ceo | Reveal Email/Phone |
2 | Founder and CEO | Reveal Email/Phone |
3 | co-founder & advisory chairman | Reveal Email/Phone |
4 | chief research officer | Reveal Email/Phone |
5 | Director Patient Advocacy and Engagement | Reveal Email/Phone |
6 | Strategic Research Analyst | Reveal Email/Phone |
7 | Biological and Strategy Consultant | Reveal Email/Phone |
8 | Senior Scientist | Reveal Email/Phone |
9 | governmental relations counsel | Reveal Email/Phone |
10 | Biological Research Consultant | Reveal Email/Phone |
SHEPHERD Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is SHEPHERD Therapeutics?
SHEPHERD’s mission is to cure rare cancers. We work closely with rare-cancer specific disease foundations to identify and pursue the highest potential translational science. We then leverage those relationships to run clinical trials which are finely attuned to the specific needs of rare cancer patients. Our platform-agnostic approach allows us to select the most technologically innovative solutions for patients and to diversify our portfolio of lead compounds across rare cancers, therapeutic platforms, and partnership and licensing structures. SHEPHERD aims to be the development partner of choice for other biopharma companies looking to expand the application of therapeutic platforms and approaches into rare and orphan indications, but which encounter P&L and other business limitations preventing them from doing so. To learn more, visit shepherd.bio. BioSpace's Top 20 Companies to Watch in 2018 Forbes 30 Under 30
keywords:N/A
N/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
-53%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.4M | 7 | -12% | N/A |
#2 | $0.4M | 7 | -68% | N/A |
#3 | $0.2M | 7 | -79% | $21.8M |
#4 | $1.8M | 7 | 17% | N/A |
#5 | $1.1M | 7 | -36% | N/A |